MA56546A - Nouveau compose carbonate possedant un squelette pyrolo-pyrimidine ou sel pharmaceutiquement acceptable de celui-ci - Google Patents

Nouveau compose carbonate possedant un squelette pyrolo-pyrimidine ou sel pharmaceutiquement acceptable de celui-ci

Info

Publication number
MA56546A
MA56546A MA056546A MA56546A MA56546A MA 56546 A MA56546 A MA 56546A MA 056546 A MA056546 A MA 056546A MA 56546 A MA56546 A MA 56546A MA 56546 A MA56546 A MA 56546A
Authority
MA
Morocco
Prior art keywords
pyrolo
pharmaceutically acceptable
acceptable salt
carbonate compound
pyrimidine skeleton
Prior art date
Application number
MA056546A
Other languages
English (en)
Inventor
Yu KOBAYAKAWA
Hitoshi Miyakoshi
Nozomu Tanaka
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of MA56546A publication Critical patent/MA56546A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/14—Pyrrolo-pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA056546A 2019-06-18 2020-06-17 Nouveau compose carbonate possedant un squelette pyrolo-pyrimidine ou sel pharmaceutiquement acceptable de celui-ci MA56546A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019113172 2019-06-18
JP2019157375 2019-08-29

Publications (1)

Publication Number Publication Date
MA56546A true MA56546A (fr) 2022-04-27

Family

ID=74036949

Family Applications (2)

Application Number Title Priority Date Filing Date
MA056546A MA56546A (fr) 2019-06-18 2020-06-17 Nouveau compose carbonate possedant un squelette pyrolo-pyrimidine ou sel pharmaceutiquement acceptable de celui-ci
MA056544A MA56544A (fr) 2019-06-18 2020-06-17 Nouveau compose ester d'acide phosphorique possedant un squelette pyrolo-pyrimidine ou sel pharmaceutiquement acceptable de celui-ci

Family Applications After (1)

Application Number Title Priority Date Filing Date
MA056544A MA56544A (fr) 2019-06-18 2020-06-17 Nouveau compose ester d'acide phosphorique possedant un squelette pyrolo-pyrimidine ou sel pharmaceutiquement acceptable de celui-ci

Country Status (12)

Country Link
US (2) US20220267365A1 (fr)
EP (2) EP3988173A4 (fr)
JP (2) JP7354245B2 (fr)
KR (2) KR20220015433A (fr)
CN (2) CN113993877A (fr)
AU (2) AU2020298440B2 (fr)
BR (2) BR112021025443A2 (fr)
CA (2) CA3143911A1 (fr)
MA (2) MA56546A (fr)
MX (2) MX2021015772A (fr)
TW (2) TW202114709A (fr)
WO (2) WO2020255978A1 (fr)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19618727C2 (de) * 1996-05-09 2000-02-17 Deutsches Krebsforsch Herstellung alkylierter Nucleosid-3'-Phosphate
US7265096B2 (en) * 2002-11-04 2007-09-04 Xenoport, Inc. Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
DE602007012881D1 (en) * 2006-07-18 2011-04-14 Anadys Pharmaceuticals Inc Carbonat- und carbamat-prodrugs von thiazolo ä4,5-dü-pyrimidinen
PL2231689T3 (pl) * 2008-01-18 2017-01-31 Inst Of Organic Chemistry And Biochemistry Of The Acad Of Sciences Of The Czech Republic Nowe 7-deazapurynowe nukleozydy o właściwościach cytostatycznych
CN102395590A (zh) * 2009-02-06 2012-03-28 Rfs制药公司 用于治疗癌症和病毒感染的嘌呤核苷单磷酸酯前药
CZ19731U1 (cs) * 2009-04-22 2009-06-15 Tuma@Stanislav Zarízení pro výrobu elektrické energie a tepla z biomasy
WO2010121576A2 (fr) * 2009-04-22 2010-10-28 Institute Of Organic Chemistry And Biochemistry Ascr,V.V.I. Nouveaux nucléosides 7-déazapurine à des fins thérapeutiques
WO2013009735A1 (fr) 2011-07-13 2013-01-17 Merck Sharp & Dohme Corp. Dérivés de nucléosides 5'-substitués et leurs procédés d'utilisation pour le traitement de maladies virales
WO2014124430A1 (fr) 2013-02-11 2014-08-14 Emory University Compositions thérapeutiques renfermant des nucléotides et des nucléosides et utilisations associées
WO2017165489A1 (fr) 2016-03-23 2017-09-28 Emory University Agents antiviraux pour le traitement d'infections par le le virus zika et de la dengue
EP3529254B1 (fr) 2016-11-03 2023-02-22 Laurence I. Wu Promédicaments de clofarabine

Also Published As

Publication number Publication date
JP7354245B2 (ja) 2023-10-02
MX2021015973A (es) 2022-02-10
AU2020298440A1 (en) 2022-01-20
EP3988173A4 (fr) 2023-08-02
TW202114708A (zh) 2021-04-16
TW202114709A (zh) 2021-04-16
EP3988174A4 (fr) 2023-04-26
MX2021015772A (es) 2022-01-31
CA3143914A1 (fr) 2020-12-24
KR20220015433A (ko) 2022-02-08
US20220233566A1 (en) 2022-07-28
WO2020255978A1 (fr) 2020-12-24
KR20220012349A (ko) 2022-02-03
JPWO2020255979A1 (fr) 2020-12-24
CA3143911A1 (fr) 2020-12-24
EP3988173A1 (fr) 2022-04-27
WO2020255979A1 (fr) 2020-12-24
JPWO2020255978A1 (fr) 2020-12-24
CN114008064A (zh) 2022-02-01
AU2020298440B2 (en) 2023-10-05
AU2020295167A1 (en) 2022-02-03
BR112021025341A2 (pt) 2022-02-01
EP3988174A1 (fr) 2022-04-27
BR112021025443A2 (pt) 2022-02-01
CN113993877A (zh) 2022-01-28
JP7354246B2 (ja) 2023-10-02
US20220267365A1 (en) 2022-08-25
MA56544A (fr) 2022-04-27

Similar Documents

Publication Publication Date Title
IL288802A (en) Benzisoxazole sulfonamide derivatives
EP3480198A4 (fr) Nouveau composé ou son sel pharmaceutiquement accepté
ZA202110352B (en) New heterocyclic compounds
EP3773566A4 (fr) Composés ox2r
ZA202107474B (en) Sulcardine salts
IL284940A (en) Bicyclic sulfonamides
EP3466945A4 (fr) Sel pharmaceutiquement acceptable utilisé en tant qu'inhibiteur du canal à potassium de la medulla externe du rein
MA56546A (fr) Nouveau compose carbonate possedant un squelette pyrolo-pyrimidine ou sel pharmaceutiquement acceptable de celui-ci
MA50937A (fr) Nouveau composé isoxazole ou sel de celui-ci
IL278054A (en) The crystalline forms of a compound
GB201919212D0 (en) Dihydro-cyclopenta-isoquinoline sulfonamides derivatives
MA41599A (fr) Formes cristallines d'un composé pyrrolopyridine
EP3803035A4 (fr) Tête modulaire pour éléments tubulaires de puits
GB201919216D0 (en) Tetrahydrobenzo-quinoline sulfonamides derivative compounds
DK3841862T3 (da) Roterende klippehoved
AU2019904248A0 (en) Sulphonamide compounds
IL290345A (en) Pyrimidine-5-carboxamide compounds
FIC20190048I1 (fi) Lorlatinibi tai sen farmaseuttisesti hyväksyttävä suola
ZA201907540B (en) A rock trepanning tool
FIC20190033I1 (fi) Apalutamidi tai sen farmaseuttisesti hyväksyttävä suola
FIC20190056I1 (fi) talatsoparibi, valinnaisesti farmaseuttisesti hyväksyttävän suolan muodossa
GB201913116D0 (en) A shower head insert
GB201904158D0 (en) Antagonist compounds
GB201907925D0 (en) A&E direct
EP4082611A4 (fr) Composé d'azétidine sulfonamide